Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
Launched by AO FOUNDATION, AO SPINE · Apr 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying different methods used in spinal fusion surgery, specifically looking at two types of rod constructs: the supplementary rod construct and the dual-rod construct. The goal is to understand how well these techniques work over time for patients who have had long-segment spinal fusions. Patients who are 45 years or older and have previously undergone this type of surgery between January 2014 and December 2020 may be eligible to participate. It's important that these patients received either a supplementary or dual-rod construct during their surgery and have at least three months of follow-up care after their procedure.
If you decide to participate in this study, your medical records will be reviewed to gather information about your surgery and recovery. This study is not currently recruiting participants, but it aims to help researchers learn more about the effectiveness and durability of these surgical techniques. Please note that certain conditions, such as recent trauma or specific diseases, may exclude individuals from participating. Your involvement could contribute to better understanding spinal fusion surgeries and improving patient care in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 45 years and older.
- • Patients receiving long-segment posterior TL instrumented fusion using either supplementary rod constructs or dual-rod constructs (the index surgery).
- • Long-segment is defined as the UIV at a thoracic level and the LIV at the sacrum/ilium.
- • Supplementary rod constructs are defined as: in addition to the traditional two primary rods, at least one supplementary rod (eg, accessory rods or satellite rods) is used, and at least one supplementary rod and one primary rod (ie, at least two rods) together must span multiple (≥ 2) vertebral levels. The supplementary rod constructs do not include rods connected end-to-end or side-to-side that do not bridge multiple vertebral levels.
- • The index surgery can be a primary surgery or a revision surgery.
- • The index surgery, staged or non-staged, must use posterior spinal fusion but can be in combination with other approaches such as an anterior procedure.
- • If the index surgery is a revision surgery, the primary rods must be replaced in the revision surgery, with the exception of Harrington or Luque rods which can remain in place.
- • o If the Harrington or Luque rods remain in situ, they must already have the UIV at the thoracic level and the LIV at the sacrum/ilium, or an extension of the existing Harrington or Luque is performed such that the UIV is at the thoracic level and the LIV at the sacrum/ilium.
- • The index surgery was performed between January 1, 2014, and December 31, 2020, inclusive.
- • Minimum 3 months of FU after the index surgery.
- • Ability to provide informed consent according to the IRB/EC defined and approved procedures if applicable for retrospective data analysis.
- Exclusion Criteria:
- • Spinal fusion performed for acute trauma (ie, ≤ 1 year of trauma).
- • Spinal fusion performed for tumor.
- • Spinal fusion performed for infection.
- • Patients with Parkinson's Disease.
- • Patients with neuromuscular disorders.
- • Patients with spine malignancies requiring chemo- or radiation therapy.
About Ao Foundation, Ao Spine
The AO Foundation, through its AO Spine division, is a leading global organization dedicated to advancing the field of spine surgery and improving patient outcomes. With a strong emphasis on education, research, and innovation, AO Spine fosters collaboration among clinicians, researchers, and industry partners to develop and implement evidence-based practices in spine care. The organization actively sponsors clinical trials and studies that aim to enhance surgical techniques, optimize treatment protocols, and evaluate new technologies, thereby contributing to the ongoing advancement of spine surgery and the overall improvement of patient health in this specialized field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charlottesville, Virginia, United States
San Francisco, California, United States
Hamamatsu, , Japan
Minneapolis, Minnesota, United States
Barcelona, , Spain
Saint Louis, Missouri, United States
Toronto, , Canada
Istanbul, , Turkey
San Francisco, California, United States
Baltimore, Maryland, United States
Washington, Missouri, United States
New York, New York, United States
Calgary, , Canada
Hong Kong, , China
Tokyo, , Japan
Redwood City, California, United States
Sacramento, California, United States
Kolkata, , India
Patients applied
Trial Officials
Justin S Smith, MD, PhD
Principal Investigator
Professor of Neurosurgery Chief of Spine Division, Fellowship Director University of Virginia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported